All news articles for January 2010

FDA highlights GMP no-no’s

FDA highlights GMP no-no’s

By Shane Starling

The Food and Drug Administration’s commitment to greater transparency is bearing fruit in the dietary supplements area, with the availability of GMP 483 reports providing valuable insights into potential GMP pitfalls.

Kiwi nutraceuticals target US

Kiwi nutraceuticals target US

By Mike Stones

New Zealand natural products companies are increasingly targeting the lucrative US nutrition market, estimated to have consumer sales of more than $101.8bn, according to the country’s NZ Trade and Enterprise organization.

Krill oil – hope or hype for the omega-3 market?

Krill oil – hope or hype for the omega-3 market?

By Stephen Daniells

Omega-3 fatty acids are one of the nutrition industry’s big fish, and an emerging presence in the market is omega-3 sourced from krill oil. Stephen Daniells casts his net for opinions on the rise of krill oil.

2009 review: FDA warning letters clampdown

2009 review: FDA warning letters clampdown

In 2008, the Food and Drug Administration (FDA) issued 44 warning letters with internet cancer claims being the primary target. In 2009, the agency upped the ante, issuing 73 letters, half of which targeted swine flu (H1N1) products. Washington DC-based...

Follow us

Products

View more

Webinars